Short Interview with Luisa Lopes

We have interviewed Luisa Lopes, the Leader of the Neurobiology of Ageing & Disease group at the Institute of Molecular Medicine (iMM) in Lisbon. In this short interview, Luisa talks about her research. She shares her opinion about the FDA approved Aduhelm (aducanumab) and how COVID-19 neurological complications are being addressed.